Loading the company…
Loading the company…
In the last ten years FDA made 4 decisions for Creo Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2023 (2). The latest was on 2023-06-26.
| Family | Decisions on record |
|---|---|
| Tumor ablation | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-06-26 | 510(k) | K223138 | AB1 Electrosurgical Instrument, Creo Electrosurgical System |
| 2023-02-14 | 510(k) | K221672 | Creo Electrosurgical System with NP1 Instrument |
| 2021-01-05 | 510(k) | K200298 | ABI Instrument, Creo Electrosurgical System |
| 2020-10-28 | 510(k) | K200003 | NP1 Instrument, Creo Electrosurgical System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Creo Medical.